VIDEO: ILCC focuses on translating data into clinical practice

ByHossein Borghaei, DO, MS

ByMarley V. Ghizzone

Hossein Borghaei, DO, MS, spoke with Healio about his important takeaways from the International Lung Cancer Congress.

“I always come away from the meeting picking up a few things here and there that I must incorporate into my own clinical practice,” Borghaei, chief of thoracic medical oncology, professor of hematology/oncology, co-director of the Immune Monitoring Facility and the Gloria and Edmund M. Dunn Chair in Thoracic Oncology at Fox Chase Cancer Center, said.

As an example, he discussed how a few years ago experts at ILCC were stressing the importance of adding liquid biopsy to practice and now many studies have been published supporting benefits of liquid biopsy.

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interview

Disclosures: Borghaei reports receiving research support from Bristol-Myers Squibb/Eli Lilly and Company, Merck/Celgene and Millennium; serving in consultant or advisory roles for AbbVie, Amgen, Astra Zeneca, Axiom, BioNTech, Boehringer Ingelheim, Bristol-Myers Squibb, Cantargia AB, Celgene, Eli Lilly and Company, EMD-Serono, Genentech, Genmab, Merck, Novartis, PharmaMar, Pfizer, Regeneron and Takeda; and serving on a data/safety monitoring board for Takeda and the University of Pennsylvania’s CAR T cell program.

Take Homes in Lung Cancer

Read more

VIDEO: ILCC focuses on translating data into clinical practice

Related Content